US 10759816
Heterocyclic compounds as RSV inhibitors
granted A61KA61K31/55A61K31/551
Quick answer
US patent 10759816 (Heterocyclic compounds as RSV inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/55, A61K31/551, A61K31/553, A61K31/554